2/3/2023 7:16:11 AM
Immunovant Q4 Net Loss $63.2 Mln Or $0.49/Shr Vs Loss $41.4 Mln Or $0.36/Shr Last Year
1/25/2022 8:39:23 AM
Immunovant Appoints Mark Levine As Chief Legal Officer
9/15/2021 7:29:03 AM
Immunovant Appoints Renee Barnett As CFO, Effective October 4